Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications

Diabetes mellitus (DM), a metabolic disorder is one of the most prevalent chronic diseases worldwide across developed as well as developing nations. Hyperglycemia is the core feature of the type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), following insulin deficiency and impaired...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nutrients 2020-09, Vol.12 (10), p.2963
Hauptverfasser:	Hashiesh, Hebaallah Mamdouh, Meeran, Mohamed F Nagoor, Sharma, Charu, Sadek, Bassem, Kaabi, Juma Al, Ojha, Shreesh K
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Inflammatory Agents - pharmacokinetics Antioxidants Antioxidants - pharmacokinetics Bioavailability Biological Availability Cannabinoid CB2 receptors Cannabinoid Receptor Agonists - pharmacokinetics Caryophyllene Cell division Complications Developing countries Diabetes Diabetes mellitus Diabetes mellitus (insulin dependent) Diabetes mellitus (non-insulin dependent) Diabetes Mellitus - therapy Diet - methods Dyslipidemia Endocannabinoid system Environmental factors Enzymes essential oils Functional foods & nutraceuticals Glucose Glucose metabolism Humans Hyperglycemia Hypoglycemic Agents - pharmacokinetics Inflammation Inflammatory diseases Insulin Insulin resistance Insulin secretion LDCs Ligands Lipid metabolism Lipids Metabolic disorders Metabolism Metabolites Molecular modelling Oxidative stress Pathogenesis Peroxisome proliferator-activated receptors Pharmaceuticals Pharmacology Phytochemicals Phytochemicals - pharmacokinetics Polycyclic Sesquiterpenes - pharmacokinetics Receptor mechanisms Review Spices Therapeutic targets β-caryophyllene
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!